title: Marked tumor response and fatal hemoptysis during radiation for lung cancer in a human immunodeficiency virus-positive patient taking nelfinavir.
authors.affiliation: Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA.
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Chapman
authors.forename: John
authors.initials: J
authors.lastname: Shen
authors.forename: Edith J
authors.initials: EJ
authors.lastname: Filion
authors.forename: Phuoc T
authors.initials: PT
authors.lastname: Tran
authors.forename: Wendy
authors.initials: W
authors.lastname: Hara
authors.forename: Alfredo
authors.initials: A
authors.lastname: Asuncion
authors.forename: Daniel
authors.initials: D
authors.lastname: Marko
authors.forename: Heather
authors.initials: H
authors.lastname: Wakelee
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Berry
authors.forename: Kevin W
authors.initials: KW
authors.lastname: Dimmick
authors.forename: Billy W
authors.initials: BW
authors.lastname: Loo
authors.forename: Jon
authors.initials: J
authors.lastname: Green
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000532:radiotherapy*; D017809:Fatal Outcome; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity; D015497:HIV-1 / Q000472:pathogenicity*; D006469:Hemoptysis / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology / Q000532:radiotherapy*; D008297:Male; D019888:Nelfinavir / Q000627:therapeutic use*
chemical_list: D017320:HIV Protease Inhibitors; D019888:Nelfinavir